Preclinical Imaging Market Analysis By Product Type (Devices: CT, MRI, PET/SPECT, Multi-modal, Optical, Ultrasound, Photoacoustic (PAT), Reagents and Services) And Segment Forecasts To 2024

Published: Mar, 2013 | Pages: 83 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)

The global Preclinical imaging market is expected to reach around USD 3.6 billion by the year 2024, according to a report performed by Grand View Research, Inc. The swift increase in the number of clinical research organizations (CROs), pharmaceutical companies, and research and development organizations is propelling the demand for preclinical imaging.

Heavy investments in research and development are encouraging research projects worldwide. As a result, the demand for Preclinical imaging is steadily increasing. Pharmaceuticals, biotechnology, life sciences, medical devices, and cosmetics are the wide application areas, where imaging modalities are widely used in research and development. Furthermore, veterinary hospitals and educational institutions also create an additional demand for this market.

North America comprises the U.S. and Canada markets. North America and Europe together accounted for the largest market share in 2015. The increased research and development funding coupled with the presence of a highly developed research infrastructure is accelerating the growth of the market in Europe and North America.

On the other hand, the governing stringent regulatory guidelines are restricting the growth of the market in North America. Asia Pacific is expected to show the fastest growth rate during the forecast period owing to the easy availability of resources, the presence of an advanced research infrastructure, and the allocation of government funds for R&D activities.

Further key findings from the study suggest:

The optical imaging devices segment captured the largest market share of the overall market in 2015. The largest market share was mainly attributed to the extensive application of these devices in small animal imaging and research projects.

The multimodal imaging devices segment is anticipated to show a significant growth rate from 2016 to 2024. The increasing adoption of these devices owing to the integration of multiple imaging modalities into a single unit is the major factor expected to drive the growth of this segment during the forecast period.

The reagents segment accounted for a significant market share in 2015 as these products are purchased repeatedly, unlike in the case of imaging devices

North America captured the largest market share of around 35% in 2015. The market is expected to maintain its dominance during the forecast period. Well-established research infrastructure, the growing number of research and development activities, and the rising investments in R&D are some of the factors supporting the growth of the market in this region.

Asia Pacific is anticipated to show a significant growth rate from 2016 to 2024 owing to the rapidly expanding contract research organization (CRO) industry in this region

The exit of the major players from the market is creating growth opportunities for the other smaller, domestic Preclinical imaging system manufacturers

The major market players include Bruker Corporation, Siemens A.G., General Electric(GE), TriFoil Imaging, PerkinElmer, Inc., VisualSonics, Inc. (Fujifilm), Mediso Ltd., MILabs B.V., and Agilent Technologies.

 Table of Contents

Chapter 1 Methodology and Scope
                    1.1 Research Methodology
                         1.1.1 Country wide market: Base estimates
                         1.1.2 Global market: CAGR calculation
                    1.2 Research Scope & Assumptions
                    1.3 List of Data Sources
Chapter 2 Executive Summary
Chapter 3 Preclinical Imaging Industry Outlook
                    3.1 Market segmentation
                    3.2 Market size and growth prospects
                    3.3 Preclinical Imaging: market dynamics
                    3.4 Market driver analysis
                        3.4.1 Increasing adaptation of diagnostic Imaging
                        3.4.2 Rising demand for non-invasive diagnostics and therapeutic devices
                    3.5 Market restraint analysis
                        3.5.1 Lack of reimbursement coverage
                        3.5.2 Strict regulatory framework
                    3.6 Key opportunities prioritized
                    3.7 Preclinical Imaging Industry Analysis - Porter's Five Forces Model
                    3.8 Preclinical Imaging Market - PESTEL Analysis
                    3.9 Preclinical Imaging: company market share analysis, 2014
                    3.10 Value Chain Analysis
Chapter 4 Preclinical Imaging Product Outlook
                    4.1 Preclinical imaging market revenue share by product, 2014 & 2024, % share
                    4.2 CT Imaging
                         4.2.1 CT Imaging Devices Market Revenue, by type, 2014 - 2024 (USD Million)
                    4.3 MRI Imaging
                         4.3.1 MRI Imaging Devices Market Revenue, 2014 to 2024 (USD Million)
                    4.4 PET/SPECT Imaging Devices
                         4.4.1 PET/SPECT Imaging Devices Market Revenue, 2014 to 2024 (USD Million)
                    4.5 Multi-modal Imaging
                         4.5.1 Multi-modal Imaging Devices Market Revenue, 2014 to 2024 (USD Million)
                    4.6 Optical Imaging
                         4.6.1 Optical Imaging Devices Market Revenue, 2014 to 2024 (USD Million)
                    4.7 Ultrasound Imaging
                         4.7.1 Ultrasound Imaging Devices Market Revenue, 2014 to 2024 (USD Million)
                    4.8 Photocoustic (PAT) Imaging
                         4.8.1 Photoacoustic (PAT) Imaging Devices Market Revenue, 2014 to 2024 (USD Million)
                    4.9 Reagents
                         4.9.1 Reagents Market Revenue, 2014 to 2024 (USD Million)
                    4.10 Services
                         4.10.1 Services Market Revenue, 2014 to 2024 (USD Million)
Chapter 5 Preclinical Imaging Market Regional Outlook
                    5.1 Preclinical imaging market share, by region, 2014 & 2024
                    5.2 North America
                         5.2.1 U.S.
                         5.2.2 Canada
                    5.3 Europe
                         5.3.1 U.K.
                         5.3.2 Germany
                    5.4 Asia Pacific
                         5.4.1 China
                         5.4.2 India
                    5.5 Latin America
                         5.5.1 Brazil
                         5.5.2 Mexico
                    5.6 Middle East and Africa (MEA)
                         5.6.1 South Africa
Chapter 6 Competitive Landscape
                    6.1 Bruker Corporation
                         6.1.1 Company Overview
                         6.1.2 Financial Performance
                         6.1.3 Product Benchmarking
                         6.1.4 Strategic Initiatives
                    6.2 Siemens A.G
                         6.2.1 Company Overview
                         6.2.2 Financial Performance
                         6.2.3 Product Portfolio
                         6.2.4 Strategic Initiatives
                    6.3 General Electric (GE)
                         6.3.1 Company Overview
                         6.3.2 Financial Performance
                         6.3.3 Product Benchmarking
                         6.3.4 Strategic Initiatives
                    6.4 TriFoil Imaging
                         6.4.1 Company Overview
                         6.4.2 Financial Performance
                         6.4.3 Product Benchmarking
                         6.4.4 Strategic Initiatives
                    6.5 PerkinElmer, Inc.
                         6.5.1 Company Overview
                         6.5.2 Financial Performance
                         6.5.3 Product Benchmarking
                         6.5.4 Strategic Initiatives
                    6.6 VisualSonics Inc. (Fujifilm)
                         6.6.1 Company Overview
                         6.6.2 Financial Performance
                         6.6.3 Product Benchmarking
                         6.6.4 Strategic Initiatives
                    6.7 Mediso Ltd.
                         6.7.1 Company Overview
                         6.7.2 Financial Performance
                         6.7.3 Product Benchmarking
                         6.7.4 Strategic Initiatives
                    6.8 MILabs B.V.
                         6.8.1 Company Overview
                         6.8.2 Financial Performance
                         6.8.3 Product Benchmarking
                         6.8.4 Strategic Initiatives
                    6.9 Agilent Technologies
                         6.9.1 Company Overview
                         6.9.2 Financial Performance
                         6.9.3 Product Benchmarking
                         6.9.4 Strategic Initiatives

List of Tables

TABLE 1 Preclinical Imaging - Industry Snapshot & Key Buying Criteria, 2014 - 2024
TABLE 2 Preclinical Imaging Market Revenue, by Product, 2014 - 2024 (USD Million)
TABLE 3 Preclinical Imaging Market Revenue, by Region, 2014 - 2024 (USD Million)
TABLE 4 Preclinical Imaging - Key Market Driver Analysis
TABLE 5 North America Preclinical Imaging Market Revenue, by Product, 2014 - 2024 (USD Million)
TABLE 6 U.S. Preclinical Imaging Market Revenue, by Product, 2014 - 2024 (USD Million)
TABLE 7 Canada Preclinical Imaging Market Revenue, by Product, 2014 - 2024 (USD Million)
TABLE 8 Europe Preclinical Imaging Market Revenue, by Product, 2014 - 2024 (USD Million)
TABLE 9 U.K. Preclinical Imaging Market Revenue, by Product, 2014 - 2024 (USD Million)
TABLE 10 Germany Preclinical Imaging Market Revenue by Product, 2014 - 2024 (USD Million)
TABLE 11 Asia Pacific Preclinical Imaging Market Revenue, by Product, 2014 - 2024 (USD Million)
TABLE 12 China Preclinical Imaging Market Revenue, by Product, 2014 - 2024 (USD Million)
TABLE 13 India Preclinical Imaging Market Revenue, by Product, 2014 - 2024 (USD Million)
TABLE 14 Latin America Preclinical Imaging Market Revenue, by Product, 2014 - 2024 (USD Million)
TABLE 15 Brazil Preclinical Imaging Market Revenue, by Product, 2014 - 2024 (USD Million)
TABLE 16 Mexico Preclinical Imaging Market Revenue, by by Product, 2014 - 2024 (USD Million)
TABLE 17 MEA Preclinical Imaging Market Revenue, by Product, 2014 - 2024 (USD Million)
TABLE 18 South Africa Preclinical Imaging Market Revenue, by Product, 2014 - 2024 (USD Million)